Delivery Order SPE2DB22D2006-SPE2DB25FW3VC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,733.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 25, 2025, with ultimate completion by August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count) valued at $1,640.40, with a firm fixed-price contract type and an ultimate completion date of July 30, 2025. This non-set-aside competitive award was issued on July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) valued at $2,707.18, with a firm fixed price structure and completion deadline of August 4, 2025. This non-set-aside award, issued on August 1, 2025, represents a single delivery order under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 60 mg tablets (100 count) valued at $1,351.82, with a firm fixed price structure and no set-aside designation. The contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units) at a ceiling value of $1,022.29. This contract is classified as firm fixed price with a non-competitive set-aside and is scheduled for completion by August 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's pharmaceutical...
- The Defense Logistics Agency awarded a $5,001.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) with an ultimate completion date of August 25, 2025. This non-set-aside contract was awarded competitively on August 22, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this...
- The Defense Logistics Agency (DLA) awarded a $2,142.97 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count packages) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which received no set-aside designation, was competitively awarded and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical will be supplied from the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for OxyContin ER 10 mg tablets (100-count units) valued at $1,494.12. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was competitively awarded. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,194.12 on August 14, 2025, for OxyContin ER 30 mg tablets (100-count supply). This firm fixed price, non-set-aside contract is part of AmerisourceBergen's broader engagement with the DLA and represents a delivery order issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3VCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) valued at $3,365.72, with a firm fixed price and no set-aside designation. This delivery order, awarded on August 25, 2025, represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA and supports the federal government's pharmaceutical supply chain operations. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical supplier to military and veteran healthcare systems. This delivery order is issued as a child contract under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The SPE2DX vehicle functions as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates its capability to compete successfully in open competition across diverse therapeutic domains, delivering everything from specialty medications to brand-name and generic drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/25/25 |